 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | Global Welfare Foundation |
| Street 1: | 14 NTC Road Brikama High way The Gambia |
| Street 2: | Po Box 1777 Banjul |
| City: | Serekunda |
| Province: | BJK |
| Post Code: | 00220 |
| Country: | Gambia |
| Phone: | 7723434 |
| Organization Email: | globalwelfarefoundation@aol.com |
| Web Site: | http://global-welfare-foundation.jimdosite.com |
| Other Online Presence: | https://www.linkedin.com/in/joe-ola-3bb193127/ |
|
|
||||||||||||||||||||||||||||
General Information | |
| Board Constituency: | None |
| Is your organization legally registered in your country: | Yes |
| If yes, please enter your registration number: | 91/2009 |
| Organization Type - Primary: | Foundation |
| Organization Type - Secondary: | Charitable / Philanthropic Foundation |
| Organization Description: | |
| GLOWEFA aims to bridge the gap of Leadership and Entrepreneurship skills by developing and transforming the minds of people for positive change. We provide charity to the poor and less privilege in the form of food, feeding program, clothing, adult literacy programs, micro-finance, sponsoring children in education and free medical treatments. Only a small proportion of those infected will become sick with TB. People with weakened immune systems have a much greater risk of falling ill from TB Treatment time can take four to nine months depending on the treatment plan. Combinations of medications may include Ethambutol, Isoniazid, Moxifloxacin, Rifampin, Rifapentine and Pyrazinamide. |
|
| Do you know about the UNHLM declaration: | Yes |
Specializations / Areas of Work | |
|
Civil Society and Community Engagement Delivery of health services and care Funding, including innovative and optimized approach to funding TB Care Provision of drugs, diagnostics and commodities Research and Development Technical Assistance Working on Key Populations related to TB |
Other Organization Information | |
| Total number of staff in your organization: | 6 - 10 |
| Number of full-time staff who are directly involved with TB: | 6 - 10 |
| Number of part-time staff who are directly involved with TB: | 6 - 10 |
| Number of volunteers who are directly involved with TB: | 6 - 10 |
| How did you hear about the Stop TB Partnership: | Stop TB communications |
| If you were informed or referred by another partner of the Stop TB Partnership please tell us who: | Nil |
| Why do you wish join the Stop TB Partnership: | Involvement in Stop TB Working Groups |
| Are you a member of a Stop TB national partnership: | No |
| Are you in contact with your national TB programme: | Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| First We collects information on each newly reported case of tuberculosis (TB) disease in the Gambia and beyond Distribution of vaccines (Bacillus Calmette-Guérin [BCG] or novel vaccine candidates still in the pipeline), identification of M. tuberculosis infection, and preventive treatment |
|
Geographical Reach | |
| Which country is your headquarters located in: | Gambia |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
Gambia |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
TB Care Delivery: Organizational Development. Capital Formation for Development through Community Savings. Training for Human Resource Development. Socio-Economic Development. conducting initial preparation, organising the community for action, exploring the health issues and setting priorities, planning, acting and evaluating together, and scaling up TB-HIV: People with HIV are more likely than people without HIV to become sick with active TB disease. This is because HIV weakens the immune system, which makes it harder for the body to fight TB germs |
|
Declaration | |
| Declaration of interests: No conflicts of interest were delacred. | |
| Application date: | February 28, 2025 |
| Last updated: | February 28, 2025 |